CharlotteEielsonAriyanMDPhD

Melanoma, Surgical Oncology (Other than Breast)

Attending Memorial Sloan-Kettering Cancer Center

Overview of Dr. Ariyan

Dr. Charlotte Ariyan is a general surgeon in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Northern Westchester Hospital. She received her medical degree from University of Vermont College of Medicine and has been in practice 20 years. Dr. Ariyan accepts several types of health insurance, listed below. She is one of 109 doctors at Memorial Sloan Kettering Cancer Center and one of 27 doctors at Northern Westchester Hospital who specialize in General Surgery. She also speaks multiple languages, including Spanish. She has more than 100 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(949) 397-6697

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2006 - 2008
Yale-New Haven Medical CenterResidency, Surgery, 1997 - 2006
University of Vermont College of MedicineClass of 1997

Certifications & Licensure

NY State Medical License 2006 - 2025
CT State Medical License 1999 - 2015
American Board of Surgery Surgery

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity Start of enrollment: 2011 Feb 01
Completed
Phase 2
Minimally Invasive Groin Dissection for Melanoma Start of enrollment: 2012 Jun 01
Completed
Not Applicable
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma Start of enrollment: 2018 Jun 05
Active, not recruiting
Phase 2
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg Start of enrollment: 2020 Apr 01
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

227 citations
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.
Cristina Valero, Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel Kelly
Nature Communications. 2021-02-01
136 citations
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff
The Lancet. Oncology. 2019-07-01
317 citations
Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity.
Chrysothemis C. Brown, Herman Gudjonson, Yuri Pritykin, Deeksha Deep, Vincent-Philippe Lavallée
Cell. 2019-10-31

Lectures

Novel Combination Immune Checkpoint Therapies
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Melanoma Stages: Prognosis, Survival Rates and TreatmentOctober 10th, 2019
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two PunchFebruary 2nd, 2018
Ludwig Researchers Devise and Test Novel Combination Therapy for Advanced MelanomaJanuary 29th, 2018
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Surgeons - ACS
Member

Other Languages

Spanish

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment